(HealthDay News) — Therapeutic decisions for diabetes should be individualized, considering factors such as ethnicity and cardiovascular (CV) risk, according to an ideas and opinions piece published in the Annals of Internal Medicine.
Giulio R. Romeo, MD, and Martin J. Abrahamson, MD, from the Joslin Diabetes Center in Boston, discuss three topics within the 2015 Standards for Diabetes Care: ethnic differences in diabetes risk with different BMIs, blood pressure (BP) targets and individualization of diabetes treatment goals.
The authors note that the American Diabetes Association endorsed a new BMI cut point for prediabetes and type 2 diabetes for Asian Americans; as well as increasing awareness of the importance of early detection of diabetes, this should prompt a reappraisal of current BMI cut points for screening in other minorities.
The 2015 Standards have adopted revised systolic and diastolic BP goals for patients with diabetes. For patients with other significant CV risk factors, or those who can achieve them without undue treatment burden, more stringent goals are recommended.
The 2015 Standards adopted revised recommendations for initiating, intensifying and monitoring adherence to statin treatment in order to reduce the risk for atherosclerotic CVD.
“The common motif of the 2015 Standards is the continued emphasis of individualizing therapeutic decisions based on factors that include ethnicity, overall risk for atherosclerotic cardiovascular disease, life expectancy, comorbid conditions, the patient’s preferences and goals, and his or her ability to adhere to treatment regimens,” the researchers wrote.